8Rajan SS, Lyman GH, Stearns SC ,et al. Effect of primary prophylactic granulocyte-colony stimulating factor use on incidence of neutropenia hospitalizations for elderly early- stage breast cancer patients receiving chemotherapy [ J ]. Med Care, 2011,49(7) :649-657.
9Wu S, Zhang Y, Xu L, et study of genetically modified al. Multicenter, randomized recombinant human interleu- kin-! 1 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy [ J ]. Support Care Cancer, 2012,20(8) : 1875 - 1884.
